Skip to content
DataLookout
Menu

FOSFORMENNCT07932158

Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible Enterobacteria

StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Clinical cure
Timeframe: At day 26

Secondary (6)

Cumulative incidence of infectious and urological complications
Adherence to treatment
Occurence of adverse events related to anticiotics
Rectal carriage of phenotypically antibiotic-resistant Enterobacterales
Rates of recurrence of febrile or non-febrile UTIs (relapse or reinfection)
Show 1 moreShow less
Number of patients who experienced treatment failure

Arms and interventions

Fosfomycin-trometamol (FT)Experimental
Reference treatments as per the French SPLIF guidlinesActive comparator

Drugs: Fosfomycin-trometamol, Reference treatments